BVMF
HAPV3
Market cap835mUSD
Oct 08, Last price
8.82BRL
1D
3.52%
1Q
-16.79%
IPO
-89.44%
Name
Hapvida Participacoes e Investimentos SA
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Hapvida Participações e Investimentos S.A., operating alongside its affiliated companies, is a key player in the Brazilian healthcare sector. The organization provides a variety of health and dental insurance plans. Its service offerings extend to direct medical and paramedical care, complemented by a suite of diagnostic services such as laboratory analysis, imaging, and ultrasound. Additionally, Hapvida supports educational initiatives by organizing courses, lectures, seminars, and similar events. The company is also involved in the administration, consultancy, deployment, and sale of individual, family, and collective healthcare systems and plans. It manages the reimbursement of medical, dental, hospital, and general healthcare expenses for its members, while simultaneously offering direct medical and hospital services. Hapvida maintains an extensive operational infrastructure, comprising 85 hospitals, 77 emergency units, 318 clinics, and 269 diagnostic centers. The company was founded in 1979 and is headquartered in Fortaleza, Brazil.
Key people
Jorge Fontoura Pinheiro Koren De Li
Chief Executive Officer, Director · since 2024
Candido Pinheiro Koren De Lima
Chairman of the Board
Luccas Adib
Chief Financial and Investor Relations Officer · since 2024
Alain Benvenuti
Chief Operating Officer
Francisco Souto
Vice President - Hospital Operations and Services · since 2023
Rafael Andrade
Vice President - Commercial · since 2023
Silvia Carame
Vice President - Costs, Medical Accounts and Sales of Services · since 2023
Luiz Celso
Vice President - Technical and Regulatory · since 2023
Milaine Lima
Vice President - Medical and Assistance Regulation and Auditing · since 2023
Kleber Linhares
Vice President - Technology and Innovation · since 2023
Andre Melo
Vice President - Infrastructure · since 2023
Jaqueline Sena
Vice President - Dental and Marketing · since 2023
Eliana Vieira
Vice President - Human Resources · since 2023
Igor Macedo Faco
Chief Legal Officer · since 2024
Gustavo Ribeiro
Chief of Institutional Relations Officer · since 2024
Candido Pinheiro Koren De Lima
Director · since 2021
Alberto Serrentino
Director · since 2022
Carlos Massaru Takahashi
Director · since 2024
Maria Aranha
Independent Director · since 2023
Jose Luis Camargo
Independent Director · since 2024
Valuation
Title BRL in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||